Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Pre-existing traits associated with Covid-19 illness severity

Open access
Ebinger, Joseph E., Achamallah, Natalie, Ji, Hongwei, Claggett, Brian L., Sun, Nancy, Botting, Patrick, Nguyen, Trevor-Trung, Luong, Eric, Kim, Elizabeth H., Park, Eunice, Liu, Yunxian, Rosenberry, Ryan, Matusov, Yuri, Zhao, Steven, Pedraza, Isabel, Zaman, Tanzira, Thompson, Michael, Raedschelders, Koen, Berg, Anders H., Grein, Jonathan D., Noble, Paul W., Chugh, Sumeet S., Bairey Merz, C. Noel, Marbán, Eduardo, Van Eyk, Jennifer E., Solomon, Scott D., Albert, Christine M., Chen, Peter, Cheng, Susan·2020·PLOS ONE

Published version of a preprint

Abstract

IMPORTANCE: Certain individuals, when infected by SARS-CoV-2, tend to develop the more severe forms of Covid-19 illness for reasons that remain unclear. OBJECTIVE: To determine the demographic and clinical characteristics associated with increased severity of Covid-19 infection. DESIGN: Retrospective observational study. We curated data from the electronic health record, and used multivariable logistic regression to examine the association of pre-existing traits with a Covid-19 illness severity defined by level of required care: need for hospital admission, need for intensive care, and need for intubation. SETTING: A large, multihospital healthcare system in Southern California. PARTICIPANTS: All patients with confirmed Covid-19 infection (N = 442). RESULTS: Of all patients studied, 48% required hospitalization, 17% required intensive care, and 12% required intubation. In multivariable-adjusted analyses, patients requiring a higher levels of care were more likely to be older (OR 1.5 per 10 years, P<0.001), male (OR 2.0, P = 0.001), African American (OR 2.1, P = 0.011), obese (OR 2.0, P = 0.021), with diabetes mellitus (OR 1.8, P = 0.037), and with a higher comorbidity index (OR 1.8 per SD, P<0.001). Several clinical associations were more pronounced in younger compared to older patients (Pinteraction<0.05). Of all hospitalized patients, males required higher levels of care (OR 2.5, P = 0.003) irrespective of age, race, or morbidity profile. CONCLUSIONS AND RELEVANCE: In our healthcare system, greater Covid-19 illness severity is seen in patients who are older, male, African American, obese, with diabetes, and with greater overall comorbidity burden. Certain comorbidities paradoxically augment risk to a greater extent in younger patients. In hospitalized patients, male sex is the main determinant of needing more intensive care. Further investigation is needed to understand the mechanisms underlying these findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0236240

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 39

  1. AE Gorbalenya, 2020, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2, Nature Microbiology, 5, 536, 10.1038/s41564-020-0695-z · DOI · Paper page
  2. E Mahase, 2020, Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate, BMJ, 368, m641, 10.1136/bmj.m641 · DOI · Paper page
  3. N Zhu, 2020, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page
  4. D Wang, 2020, Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, JAMA
  5. CC Lai, Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status, Int J Antimicrob Agents, 2020, 105946
  6. E Livingston, 2020, Coronavirus Disease 2019 (COVID-19) in Italy, JAMA
  7. P Kinross, 2020, Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020, Euro Surveill, 25, 10.2807/1560-7917.ES.2020.25.11.2000285 · DOI
  8. nCo VCDCRT, 2020, Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak—United States, December 31, 2019-February 4, 2020, MMWR Morb Mortal Wkly Rep, 69, 140, 10.15585/mmwr.mm6905e1 · DOI · Paper page
  9. C Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  10. N Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
  11. WJ Guan, 2020, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med
  12. K Liu, 2020, Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chinese medical journal
  13. C Wu, 2020, Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med
  14. F Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
  15. Z Wu, 2020, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention, JAMA
  16. ME Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  17. H Quan, 2011, Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries, Am J Epidemiol, 173, 676, 10.1093/aje/kwq433 · DOI · Paper page
  18. H Quan, 2005, Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data, Medical Care, 43, 1130, 10.1097/01.mlr.0000182534.19832.83 · DOI · Paper page
  19. MT Sharabiani, 2012, Systematic review of comorbidity indices for administrative data, Med Care, 50, 1109, 10.1097/MLR.0b013e31825f64d0 · DOI · Paper page
  20. DA Southern, 2004, Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data, Med Care, 42, 355, 10.1097/01.mlr.0000118861.56848.ee · DOI · Paper page
  21. GJ Stukenborg, 2001, Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations, Med Care, 39, 727, 10.1097/00005650-200107000-00009 · DOI · Paper page
  22. A Garland, 2012, The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province, Med Care, 50, e1, 10.1097/MLR.0b013e318245a754 · doi:10.1097/mlr.0b013e318245a754
  23. CW Yancy, 2020, COVID-19 and African Americans, JAMA
  24. DH Ryan, 2020, COVID 19 and the Patient with Obesity—The Editors Speak Out, Obesity (Silver Spring)
  25. R Muniyappa, 2020, COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus, Am J Physiol Endocrinol Metab
  26. E Maddaloni, Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics, Diabetes Metab Res Rev, 2020, e33213321
  27. RCW Ma, 2020, COVID-19 and diabetes, Diabet Med
  28. W Guo, Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes Metab Res Rev, 2020, e3319
  29. A Simonnet, 2020, High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Obesity (Silver Spring)
  30. M AlGhatrif, 2020, The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science, JAMA Cardiol
  31. Y Shi, 2020, Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan, Crit Care, 24, 108, 10.1186/s13054-020-2833-7 · DOI · Paper page
  32. AT Lely, 2004, Renal ACE2 expression in human kidney disease, The Journal of pathology, 204, 587, 10.1002/path.1670 · DOI · Paper page
  33. PL Dalpiaz, 2015, Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats, PLoS One, 10, e0127515, 10.1371/journal.pone.0127515 · DOI
  34. AK Sampson, 2012, Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats, Gender medicine, 9, 21, 10.1016/j.genm.2011.12.003 · DOI
  35. IG Alghamdi, 2014, The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health, Int J Gen Med, 7, 417, 10.2147/IJGM.S67061 · DOI · Paper page
  36. J Karlberg, 2004, Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?, Am J Epidemiol, 159, 229, 10.1093/aje/kwh056 · DOI · Paper page
  37. R Channappanavar, 2017, Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection, J Immunol, 198, 4046, 10.4049/jimmunol.1601896 · DOI · Paper page
  38. M Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell
  39. TWK Lew, 2003, Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory Syndrome, JAMA, 290, 374, 10.1001/jama.290.3.374 · DOI · Paper page

Cited by

See all 169

Metadata

Authors
Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., Nguyen, T.-T., Luong, E., Kim, E. H., Park, E., Liu, Y., Rosenberry, R., Matusov, Y., Zhao, S., Pedraza, I., Zaman, T., Thompson, M., Raedschelders, K., Berg, A. H., Grein, J. D., Noble, P. W., Chugh, S. S., Bairey Merz, C. N., Marbán, E., Van Eyk, J. E., Solomon, S. D., Albert, C. M., Chen, P., & Cheng, S.
Venue
PLOS ONE
Published
2020-07-23
Volume
15
Issue
7
Pages
e0236240
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3044132448
Cited by
169
References
11
FWCI
4.26
Type
journal article
Language
en
Open access
gold
Funders
Erika J. Glazer Family Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-existing traits associated with Covid-19 illness severity. https://app.cochat.ai/papers/10.1371/journal.pone.0236240
The paper
Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P., Nguyen, T.-T., Luong, E., Kim, E. H., Park, E., Liu, Y., Rosenberry, R., Matusov, Y., Zhao, S., Pedraza, I., Zaman, T., Thompson, M., Raedschelders, K., Berg, A. H., . . . Cheng, S. (2020). Pre-existing traits associated with Covid-19 illness severity. PLOS ONE. https://doi.org/10.1371/journal.pone.0236240

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.